Compare IVA & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVA | MLAB |
|---|---|---|
| Founded | 2011 | 1982 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 796.1M | 719.9M |
| IPO Year | 2020 | 1995 |
| Metric | IVA | MLAB |
|---|---|---|
| Price | $3.12 | $127.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | $15.20 | ★ $117.50 |
| AVG Volume (30 Days) | ★ 2.3M | 91.2K |
| Earning Date | 09-28-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 0.50% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | N/A | $6.45 |
| P/E Ratio | ★ N/A | $260.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.11 | $67.89 |
| 52 Week High | $7.98 | $144.35 |
| Indicator | IVA | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 32.53 | 49.29 |
| Support Level | N/A | $89.77 |
| Resistance Level | $4.80 | $132.70 |
| Average True Range (ATR) | 0.25 | 5.13 |
| MACD | -0.00 | -1.26 |
| Stochastic Oscillator | 3.08 | 14.59 |
Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.